Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
25 Aprile 2024 - 2:00PM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,
diversified specialty pharmaceutical company committed to improving
the lives of people living with serious medical conditions, today
announced that it will report first quarter 2024 financial results
after the market closes on Thursday, May 9, 2024. Following
the release of the financials, the Company will host a live
conference call and webcast at 4:30 p.m. ET.
Conference Call Information To access the
conference call, please dial (877) 407-8037 (U.S.) or (201)
689-8037 (International) and reference the “Collegium
Pharmaceutical Q1 2024 Earnings Call.” An audio webcast will be
accessible from the Investors section of the Company’s
website: www.collegiumpharma.com. The webcast will be
available for replay on the Company’s website approximately two
hours after the event.
About Collegium Pharmaceutical,
Inc.Collegium is a leading, diversified specialty
pharmaceutical company committed to improving the lives of people
living with serious medical conditions. Collegium’s headquarters
are located in Stoughton, Massachusetts. For more information,
please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher James, M.D.Vice
President, Investor Relationsir@collegiumpharma.com
Media Contact:Marissa SamuelsVice President,
Corporate Communicationscommunications@collegiumpharma.com
Grafico Azioni Collegium Pharmaceutical (NASDAQ:COLL)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Collegium Pharmaceutical (NASDAQ:COLL)
Storico
Da Gen 2024 a Gen 2025